glp-1 news insurers Insurance companies scrambling to support need for drugs - Insurance Health insurer Cigna will stop

GLP-1 medications have the potential to revolutionise the way we approach weight management and diabetes treatment

Some potential future developments in continuous glucose monitoring include: Smaller and more discreet sensors As technology progresses, CGM sensors are likely to become even smaller and more discreet, offering enhanced comfort and wearability

Do not use if solution is not clear or if particulate matter is present

Taken together, these moves suggest Nestl is prioritizing fewer, clearer growth platforms, and ones tied to culinary credibility, daily rituals and higher perceived value instead of stretching itself across too many categories at once

Slower digestion and reduced appetite can sometimes lead to lower fluid intake